Skip to main content

Editorial reviews. Affiliate fees from some providers don't affect rankings. Disclosure

No advertiser influenceAffiliate fees disclosedReviewed by board-certified clinicians

FSH testing in perimenopause: when it helps and when it misleads

FSH testing is widely ordered for perimenopause but the single value fluctuates so much it usually misleads. Knowing the test's limits prevents wasted appointments.

2 min readReviewed May 2026

Affiliate link Advertiser Disclosure: This site is reader-supported. We may earn an affiliate commission when you sign up for a service through links on our site. This does not influence our editorial recommendations or medical reviews. Read our full disclosure.

Follicle-stimulating hormone (FSH) is one of the most-ordered tests in women asking "am I in perimenopause?" — and one of the most overinterpreted. Levels swing widely across the transition, and a single result rarely answers the question reliably.

What FSH measures

FSH is produced by the pituitary and signals the ovaries to mature follicles. As ovarian reserve declines, less estrogen is produced, the pituitary loses negative feedback, and FSH rises. In the reproductive years, FSH peaks briefly at ovulation and otherwise sits below 10 mIU/mL. In postmenopause, FSH stabilizes above 25–30 mIU/mL, sometimes reaching 70+ mIU/mL.

The fluctuation problem

During perimenopause, FSH does not rise smoothly. It bounces — high one month, near-premenopausal the next, driven by intermittent ovarian function. A 2007 SWAN study sub-analysis found that single FSH measurements correctly classified menopausal status in only about 60% of late-transition women. This is why the STRAW+10 framework — the global staging consensus — explicitly demotes FSH from a primary staging tool to a secondary check.

When the test is useful

FSH adds value in specific situations. After a hysterectomy with ovaries intact, there's no menstrual history to stage from — FSH plus symptom profile fills the gap. In suspected premature ovarian insufficiency (POI) under age 40, FSH > 25 mIU/mL on two readings 4–6 weeks apart is part of the diagnostic criteria. For women considering fertility planning, FSH adds context to anti-müllerian hormone (AMH) and antral follicle counts.

When the test misleads

FSH is unreliable in any of the following: while on hormonal contraception (estradiol suppresses pituitary FSH artificially), within 6 weeks of stopping oral contraceptives, with anovulatory cycles from PCOS or hypothalamic causes, or as a single value across the noisy mid-transition. If a clinician orders FSH for any of these, ask whether the result will actually change management.

What to test instead

For perimenopausal symptoms, the most useful workup is usually: TSH (rule out thyroid mimicking peri), CBC and ferritin (rule out anemia and iron deficiency, especially with heavy bleeding), vitamin D and B12 (if cognitive or mood symptoms predominate), and fasting glucose with A1c (rule out insulin resistance for weight changes). The diagnosis of perimenopause is primarily clinical — symptoms plus cycle pattern — not laboratory-driven.

Informational only — your clinician decides which labs make sense for your situation.

How we work — three pages, three answers